Skip to content
Home
Journalists
Headlines
Community
Businesses
Jobs
Learning
Marketplace
Store
(@)
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.
Author:
Lauren Hirsch
Written by
Lauren Hirsch
in
Drugs (Pharmaceuticals)
,
Food and Drug Administration
,
Karuna Therapeutics Inc
,
Mental Health and Disorders
,
Mergers, Acquisitions and Divestitures
←
Trump Insists He’s ‘Not A Student Of Hitler’ While Defending ‘Poisoning The Blood’ Comments About Immigrants
Joe Rogan Corrected On His Own Show For Dissing Biden…By Quoting Trump
→
More posts
Protesters, leaders push back against DHS over Newark detention facility conditions
Goldman and Lander spar hard over Israel
Snowflake climbs after Q1 results top expectations, guidance gets a boost
Synopsys drops despite better than expected Q2 results, big boost to full-year guidance